(Q37594567)

21 August 2017

1 reference

title

Atypical depression: useful concept, but it's time to revise the DSM-IV criteria (English)

1 reference

21 August 2017

Michael E Thase

1

1 reference

21 August 2017

language of work or name

English

0 references

publication date

9 September 2009

1 reference

21 August 2017

published in

Neuropsychopharmacology

1 reference

21 August 2017

volume

34

1 reference

21 August 2017

issue

13

1 reference

21 August 2017

page(s)

2633-2641

1 reference

Toward validation of atypical depression in the community: results of the Zurich cohort study.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Atypical depressive syndromes in varying definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Pattern-reversed visual evoked potentials in subtypes of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

A new view on hypocortisolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Treatment of depression with atypical features: a meta-analytic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Depression with atypical features in a sample of primary care outpatients: prevalence, specific characteristics and consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Tranylcypromine versus imipramine in anergic bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

The validity of major depression with atypical features based on a community study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

The identification and validation of distinct depressive syndromes in a population-based sample of female twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Familiality of symptom dimensions in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Reversed neurovegetative symptoms of depression: a community study of Ontario.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Major depression in individuals with a history of childhood physical or sexual abuse: relationship to neurovegetative features, mania, and gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Antidepressant specificity in atypical depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Biological and clinical validation of atypical depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Atypical depression: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Symptoms of atypical depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Monoamine oxidase inhibitors in bipolar endogenous depressives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Monoamine oxidase inhibitors. A review of antidepressant effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Do age of onset and course of illness define biologically distinct groups within atypical depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Direction of weight change in recurrent depression. Consistency across episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

The subtypes of major depression in a twin registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Treatment of imipramine-resistant recurrent depression, IV: A double- blind crossover study of tranylcypromine for anergic bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Effects of iproniazid in depressive syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Factors that differentiate early vs. later onset of major depression disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

A Placebo-Controlled Study of Fluoxetine Versus Imipramine in the Acute Treatment of Atypical Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

7 January 2021

Cerebral laterality and depression: differences in perceptual asymmetry among diagnostic subtypes

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

7 January 2021

Atypical depression: enhanced right hemispheric dominance for perceiving emotional chimeric faces

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

7 January 2021

A double-blind study of tranylcypromine treatment of major anergic depression

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

7 January 2021

Treatment of melancholia with tranylcypromine

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

7 January 2021

Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes?

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

7 January 2021

Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

7 January 2021

Fluoxetine versus phenelzine in atypical depression

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

7 January 2021

Partial validation of the atypical features subtype of major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

7 January 2021

Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

7 January 2021

The Inventory of Depressive Symptomatology (IDS): psychometric properties.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

7 January 2021

Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

7 January 2021

MAOIs in the Contemporary Treatment of Depression

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.100

7 January 2021

Identifiers

DOI

10.1038/NPP.2009.100

1 reference

21 August 2017

1 reference